Patents by Inventor Quingfu Zeng

Quingfu Zeng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-alpha
    Publication number: 20160193208
    Abstract: The invention discloses a previously unidentified subset of mammalian non-small cell lung carcinomas (NSCLC) in which platelet-derived growth factor receptor alpha (PDGFR?) is expressed and is driving the disease, and provides methods for identifying a mammalian NSCLC tumor that belongs to a subset of NSCLC tumors in which PDGFR? is expressed, and for identifying a NSCLC tumor that is likely to respond to a PDGFR?-inhibiting therapeutic. The invention also provides methods for inhibiting the progression of a mammalian NSCLC tumor in which PDGFR? is expressed, and for determining whether a compound inhibits the progression of a PDGFR?-expressing mammalian NSCLC tumor.
    Type: Application
    Filed: September 8, 2015
    Publication date: July 7, 2016
    Inventors: Klarisa Rikova, Roberto Polakiewicz, Ailan Guo, Katherine Eleanor Crosby, Quingfu Zeng, Kimberly A Lee
  • Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-ALPHA
    Publication number: 20130266965
    Abstract: The invention discloses a previously unidentified subset of mammalian non-small cell lung carcinomas (NSCLC) in which platelet-derived growth factor receptor alpha (PDGFR?) is expressed and is driving the disease, and provides methods for identifying a mammalian NSCLC tumor that belongs to a subset of NSCLC tumors in which PDGFR? is expressed, and for identifying a NSCLC tumor that is likely to respond to a PDGFR?-inhibiting therapeutic. The invention also provides methods for inhibiting the progression of a mammalian NSCLC tumor in which PDGFR? is expressed, and for determining whether a compound inhibits the progression of a PDGFR?-expressing mammalian NSCLC tumor.
    Type: Application
    Filed: February 28, 2013
    Publication date: October 10, 2013
    Applicant: CELL SIGNALING TECHNOLOGY, INC.
    Inventors: Klarisa Rikova, Roberto Polakiewicz, Ailan Guo, Katherine Eleanor Crosby, Quingfu Zeng, Kimberly A. Lee